1-2 of 2
Nanne Aben
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract C007: A high-throughput screen to identify effective and translationally-relevant drug combinations for breast, colorectal, and pancreatic cancers

Elizabeth A Coker, Patricia Jaaks, Daniel J Vis, Nanne Aben, Syd Barthorpe, Dieudonne van der Meer, Howard Lightfoot, Lodewyk Wessels, Mathew Garnett, GDSC Screening Team
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): C007.
https://doi.org/10.1158/1535-7163.TARG-19-C007
Published: 01 December 2019
View article titled, Abstract C007: A high-throughput screen to identify effective and translationally-relevant drug combinations for breast, colorectal, and pancreatic cancers
Journal Articles

Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin

Remco Nagel, Ana Teresa Avelar, Nanne Aben, Natalie Proost, Marieke van de Ven, Jan van der Vliet, Miranda Cozijnsen, Hilda de Vries, Lodewyk F. A. Wessels, Anton Berns
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2019) 18 (4): 762–770.
https://doi.org/10.1158/1535-7163.MCT-18-0972
Published: 01 April 2019
View article titled, Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin
Open the PDF for Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin in another window
Includes: Supplementary data